icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
HJW3UYwJWUTyypm3
Listen
